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Neutrophils are cells of the immune system which freely 
circulate in blood vessels and are recruited to the inflam-
mation sites when the human organism responds to mi-
crobial infections. One of the mechanisms of neutrophil 
action is the formation of neutrophil extracellular traps 
(NETs) The process of NET generation, called netosis, is 
a specific type of cell death, different from necrosis and 
apoptosis. NETs are formed by neutrophils upon contact 
with various bacteria or fungi as well as with activated 
platelets or under the influence of numerous inflam-
matory stimuli, and this process is associated with dra-
matic changes in the morphology of the cells. The main 
components of NETs, DNA and granular antimicrobial 
proteins, determine their antimicrobial properties. The 
pathogens trapped in NETs are killed by oxidative and 
non-oxidative mechanisms. On the other hand, it was 
also discovered that chromatin and proteases released 
into the circulatory system during NET formation can 
regulate procoagulant and prothrombotic factors and 
take part in clot formation in blood vessels. NETs have 
also been detected in lungs where they are involved in 
chronic inflammation processes in ALI/ARDS patients. 
Moreover, DNA-proteins complexes have been found in 
the airway fluids of cystic fibrosis patients where they 
can increase the viscosity of the sputum and have a neg-
ative impact on the lung functions. The DNA-complexed 
granular proteins and other proteins released by neu-
trophils during netosis lead to autoimmunity syndromes 
such as systemic lupus erythematosus (SLE), small-vessel 
vasculitis (SVV) or autoimmune diseases associated with 
the formation of autoantibodies against chromatin and 
neutrophil components. A possible involvement of NETs 
in metastasis is also considered.
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INTRODUCTION
Neutrophils are important components of innate im-
munity necessary to maintain homeostasis of the organ-
ism. They are short-lived polymorphonuclear granulo-
cytes which constitute a primary defence against microbi-
al infections. In acute inflammation, neutrophils circulat-
ing with the bloodstream are rapidly recruited to the site 
of infection, in response to chemotactic factors released 
by pathogens or host cells. After attachment to the en-
dothelium, neutrophils leave blood vessels and move to-
ward the site of infection, sensing the chemotactic gra-
dient. At the inflammatory site, activated immune cells 
acquire the ability to kill pathogens. To fulfill that task, 
neutrophils use a number of strategies such as phagocy-
tosis, degranulation and the recently discovered forma-
tion of extracellular traps. During phagocytosis, internal-
ized pathogens are translocated to phagosomes where 
the antimicrobial factors derived from granules and reac-
tive oxygen species (ROS) create a killing environment 
for pathogens. The second mechanism, degranulation, is 
similar to phagocytosis, but rather than being engulfed 
the pathogens are killed extracellularly by the same an-
timicrobial factors which are in part released outside 
the cell. The neutrophil extracellular traps (NETs) can 
be released by neutrophils in a process called netosis. 
NETs are a special kind of trap formed by decondensed 
chromatin fibres decorated with antimicrobial factors 
delivered by the granules. The main function of NETs 
is trapping and killing of pathogens (Brinkmann et al., 
2004).
NETOSIS
Netosis is a specific type of cell death different from 
both necrosis and apoptosis but its mechanism is still 
poorly understood (Fuchs et al., 2007). The most impor-
tant feature specific to NETs is the presence of neutro-
phil nuclear DNA fibres in the extracellular space. NETs 
are produced by neutrophils in contact with pathogens 
such as bacteria, fungi, viruses and protozoa (Table 1), 
with a variety of host factors such as activated platelets 
or inflammatory stimuli or with chemical compounds 
(e.g. phorbol-12-myristate-13-acetate) (Brinkmann et al., 
2004).
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Molecular basis of NET generation
Netosis is a complex process (Fig. 1) that differs in 
details depending on the stimulus and occurs with dra-
matic changes in the morphology of the neutrophil cell 
that finally lead to cell death. Neeli et al. (2008) have 
proposed that the MAC-1 integrin may be involved in 
the initiation of changes in the neutrophil cytoskeleton 
that facilitate the breakdown of nuclear and plasma 
membranes for the release of NETs. However, a precise 
stimulus recognition and mechanisms involved in the se-
lection of further responses (phagocytosis versus netosis) 
remain to be discovered.
Several factors and 
events were proposed to 
be engaged in netosis. The 
timing of NET forma-
tion and the dependency 
on ROS production, NET 
composition and the in-
volvement of cell death dif-
fer depending on the type 
of stimulus used in the 
NET studies. Nevertheless, 
some of the fundamental 
steps have been determined 
(Papayannopoulos & Zy-
chlinsky, 2009; Parker & 
Winterbourn, 2012). Dur-
ing activation, neutrophils 
produce large amounts of 
ROS through the action of 
NADPH oxidase (PHOX) 
Fuchs et al. (2007) have 
presented evidence that 
ROS are also initiators of 
NET production. For ex-
ample, neutrophils from 
chronic granulomatous dis-
ease (CGD) patients cannot 
produce NETs as CGD 
results from a mutation in 
PHOX subunits that affects 
the enzyme activity. How-
ever, treatment of CGD-
neutrophils with H2O2 re-
stored their ability to form 
NETs (Fuchs et al., 2007; 
Nishinaka et al., 2011).
After stimulation, the neutrophil chromatin under-
goes decondensation followed by mixing of euchroma-
tin and heterochromatin (Fuchs et al., 2007). This pro-
cess is mediated by enzymes stored in the azurophilic 
granules, neutrophil elastase (NE) and myeloperoxidase 
(MPO), which are relocated to the nucleus by a yet un-
known mechanism. First, NE degrades the linker histone 
H1 and the core histones, leading to chromatin decon-
densation which is enhanced by MPO, independent of 
the enzymatic activity of the latter (Papayannopoulos et 
al., 2010; Metzler et al., 2011). Moreover, during NET 
formation, histone H3 
undergoes a modification 
(the “citrullination”) that 
converts arginine residues 
to citrulline (Wang et al., 
2009; Leshner et al., 2012; 
Neeli & Radic, 2013). 
The citrullination of his-
tones is catalysed by pep-
tidylarginine deiminase 4 
(PAD4) which is localized 
in the nucleus of neutro-
phils. It was shown that 
neutrophils isolated from 
PAD4-knockout mice 
lost their ability to release 
NET and histone hyper-
citrullination was not de-
tectable (Li et al., 2010). 
Subsequently, the nuclear 
membrane is damaged, 
chromatin expands inside 
Table 1. Microbial and chemical factors which stimulate the formation of NETs
(Guimarães-Costa et al., 2012).
Microbial factors Chemical factors
Aspergillus fumigatus δ-Toxin from Staphylococcus epidermidis
Candida albicans Antibodies
Cryptococcus gattii Calcium ions
Cryptococcus neoformans Glucose oxidase
Eimeria bovis GM-CSF +C5a
Enterococcus faecalis GM-CSF + LPS
Escherichia coli Hydrogen peroxide
Haemophilus influenzae Interferon-α + C5a
Helicobacter pylori Interleukin 8
Klebsiella pneumoniae Lipopolysaccharide (LPS)
Lactococcus lactis M1 protein
Leishmania amazonensis donovani/major/chagasi Nitric oxide
Listeria monocytogenes Phorbol-12-myristate-13-acetate (PMA)
Mannheimia haemolytica PMA + ionomycin
Mycobacterium tuberculosis/canettii Platelet activating factor
Serratia marcescens TLR-4
Shigella flexneri TNF-α
Staphylococcus aureus
Streptococcus dysgalactiae
Streptococcus pneumonia
Yersinia enterocolitica
Figure 1. Mechanism of NET release. 
Stimulation of receptors (A) by triggers (e.g. bacteria, fungi, viruses, parasites, chemical factors like 
PMA or LPS) leads to the adherence of neutrophils to endothelium and to chromatin decondensa-
tion due to histone cleavage by NE and MPO and histone hypercitrullination by PAD4 (B). In the final 
phase, NETs are released and trap bacteria (C).
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the cell and is mixed with granular antimicrobial fac-
tors. Finally, the cell membrane breaks releasing NETs 
(Brinkmann & Zychlinsky, 2012).
All these processes presented above determine a new 
type of neutrophil death but NETs can be also released 
within minutes from living neutrophil cells through an 
oxidant-independent mechanism as it was demonstrated 
in S. aureus infection (Pilsczek et al., 2010; Yipp et al., 
2012). Given that other cell types (mast cells, basophils 
and macrophages) are also able to form extracellular 
traps (ETs) (Goldmann & Medina, 2013), this new de-
fence process, collectively named etosis, still remains a 
mystery.
NET antimicrobial actions
NETs are able to trap almost all types of pathogens, 
even those so large that they cannot be phagocytosed, 
including gram-positive and gram-negative bacteria, 
yeasts, viruses and protozoan parasites (Lu et al., 2012). 
The trapping within the DNA fibres prevents the spread 
of microorganisms over the body and facilitates a high-
er concentration of antimicrobial factors at the site of 
infection (Brinkmann et al., 2004). The trapping occurs 
through charge interactions between the pathogen cell 
surface and NET components. Their antimicrobial func-
tions are represented by proteins originating from both 
the granules and the cytoplasm i.e., not only NE, his-
tone and MPO but also cathepsin G, proteinase 3 (PR3), 
lactoferrin, calprotectin and antimicrobial peptides such 
as defensins or the cationic antimicrobial protein-derived 
peptide LL37 (Urban et al., 2009). NET-associated pro-
teases (NE or PR3) can inactivate and kill pathogens by 
cleaving their virulence factors (Brinkmann et al., 2004). 
LL37 and histones can disintegrate the pathogen cell 
membranes, challenging the pathogen viability (Cho et 
al., 2009; Méndez-Samperio, 2010). The activity of MPO 
is essential for killing S. aureus (Parker & Winterbourn, 
2012), but fungal growth is restricted by neutrophil pro-
teins which act in ion sequestration such as lactoferrin or 
calgranulin (Farnaud & Evans, 2003; Urban et al., 2009).
However, NETs are not perfect in microbe killing 
and some pathogens have evolved mechanisms to evade 
NETs. Such mechanism, identified in S. aureus, or S. pyo-
genes is based on the secretion of endonucleases which 
degrade DNA (Beiter et al., 2006). On the other hand, 
pathogens may also avoid trapping by changing their 
surface charge or making a polysaccharide capsule such 
as that formed by S. pneumonia (Wartha et al., 2007).
NETS AND INFLAMMATION
Besides the proposed antibacterial function of NETs, 
their ineffective clearance or excessive formation can 
cause several pathological effects. NET formation was 
observed during chronic inflammatory disease (athero-
sclerosis), autoimmune diseases (SLE), in diverse forms 
of vasculitis, thrombosis, transfusion-related acute lung 
injury (TRALI) and in cancer. Although temporary, the 
new structure which contains DNA scaffold associ-
ated with antimicrobial proteins and proteases presents 
a platform for additional signaling or interactions with 
blood or tissue components. Studies on NET cyto-
toxicity towards endothelial and epithelial cells pointed 
out histones, MPO, NE and cathepsin G as the main 
NET components involved in tissue destruction, where-
as lungs are the main target as neutrophils reside in 
the lung longer than in other organs (Kolaczkowska & 
Kubes, 2013).
Lung diseases
One consequence of chronic lung inflammation is 
the acute lung injury (ALI) and acute respiratory dis-
tress syndrome (ARDS) (Ware & Matthay, 2000; Cheng 
& Palaniyar, 2013). Additional risk factors (pathogenic 
infection, sepsis, chronic allergy as well as mechanical 
ventilation with high pressure, or transfusions) can lead 
to the injury of alveolar epithelial cells and increase the 
permeability of alveolar and capillary vessels (Ware & 
Matthay, 2000). The activation and massive migration of 
neutrophils into the alveolar space, 
controlled by chemokines produced 
by epithelial cells, macrophages as 
well as neutrophils (Kasama et al., 
2005), was observed in infection-
related ALI/ARDS and in the ster-
ile injury. A high concentration of 
stimulating factors present in the 
alveolar space promotes neutrophil 
activation and NET release (Fig. 2). 
On the other hand, the lower level 
of surfactant proteins (SP-A and 
SP-B) in the pulmonary surfactant 
layer, frequently observed in sev-
eral inflammatory lung diseases, is 
responsible for a defective NET-
nucleic acid clearance (Douda et 
al., 2011; Nayak et al., 2012). Also, 
the proteinous NET components 
are potent lung injury factors. NE 
cleaves endothelial actin cytoskel-
eton, E-cadherin and VE-cadherin, 
increasing the permeability of the 
alveolar-capillary barrier. Moreover, 
NE induces apoptosis of epithelial 
cells and the release of proinflam-
matory cytokines (Saffarzadeh et 
al., 2012). Other proteinases (PR3, 
cathepsin G) are able to regulate 
Figure 2. Alveolar space in ALI/ARDS. 
Injury of alveolar epithelial cells increases the permeability of the barrier between the al-
veolar space and blood vessels. Additionally, the epithelium releases IL-8. Those condi-
tions promote a leakage of neutrophils with the edema fluid into the alveolar space (A). 
Inside alveoli neutrophils release NETs in response to stimulating factors (B). The NET 
components, such as proteinases or ROS, cause secondary epithelial cell damage, leading 
to chronic inflammation (C).
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the inflammatory process by activating proinflammatory 
and degrading anti-inflammatory proteins (Grommes & 
Soehnlein, 2011). The antimicrobial peptide LL-37, de-
tected in NET structures (Urban et al., 2009), presents 
cytotoxic and proapoptotic properties towards endothe-
lial and epithelial cells (Aarbiou et al., 2006). In addi-
tion, ROS produced by MPO cause epithelial cell inju-
ry, which leads to apoptosis or necrosis (Grommes & 
Soehnlein, 2011), besides ROS-promoted netosis (Nishi-
naka et al., 2011).
Similarly, the antibacterial and proinflammatory role 
of NETs was observed in cystic fibrosis (CF) patients 
(Fig. 3) CF is a lung disease resulting from a mutation 
in the cystic fibrosis transmembrane conductance regula-
tor (Ratjen & Grasemann, 2012). This mutation disrupts 
the normal transport of Na+ and Cl- ions across epi-
thelial cells causing dehydration and an increase in mu-
cus viscosity, therefore hindering the clearance of mu-
cus from the airways (Kaynar & Shapiro, 2010; Ratjen & 
Grasemann, 2012). Another factor responsible for high 
mucus viscosity is the presence of DNA in CF patient 
sputum (Henke & Ratjen, 2007) that correlates with a 
high concentration of neutrophils and NET accumula-
tion in CF lungs (Marcos et al., 2010). Increased levels 
of neutrophils lead to chronic neutrophilic inflammation, 
observed in CF patients, mostly caused by chronic bacte-
rial and viral infections enhanced by conditions favoring 
microbial growth. Moreover, the NET production, addi-
tionally promoted by bacterial infection in CF airways, 
is often ineffective in bacterial killing as was presented 
for Pseudomonas aeruginosa (Marcos et al., 2010), and may 
facilitate bacterial airway colonisation and biofilm for-
mation. Those conditions, often accompanied by a de-
creased SP-D level, lead to the increase in mucus viscos-
ity and consequently to chronic inflammation (Cheng & 
Palaniyar, 2013).
One of the currently proposed therapies for sputum 
viscosity reduction of which NET structures are the tar-
gets, is mucus DNA degradation by recombinant human 
DNase (rhDNase) (Henke & Ratjen, 2007). However, 
rhDNase is able to digest free 
chromatin more quickly than 
the DNA-protein complexes 
occurring in NETs. The role 
of NE in CF is ambiguous. 
On the one hand, Papayanno-
poulos et al. (2011) have pre-
sented data that NE enhances 
solubilization of sputum by 
degrading histones and facili-
tating the access for rhDNase. 
On the other hand, the liber-
ated elastase as well as other 
proteolytic NET components 
can damage lung tissue and 
enhance the immune response 
by modulating the inflam-
matory factors. For exam-
ple, active proteases are able 
to degrade SP-D, during the 
course of pathogenic infection 
(Cheng & Palaniyar, 2013). 
However, NE in CF sputum 
is predominantly bound to 
DNA, which down-regulates 
its proteolytic activity but also 
precludes the inhibition by 
exogenous protease inhibitors 
(Dubois et al., 2012). Taking 
into account the benefits and 
problems resulting from the mucolytic therapy, it seems 
reasonable to introduce a combination therapy with rh-
DNase and protease inhibitors, which should offer the 
best compromise between lung tissue injury and easy 
mucus removal.
Autoimmune diseases
Autoimmune diseases such as small vessel vasculitis 
(SVV) or systemic lupus erythematosus (SLE) are other 
examples of the dark side of NET production and their 
ineffective clearance (Sangaletti et al., 2012; Brinkmann & 
Zychlinsky, 2012; Darrah & Andrade, 2012). Although 
the development of autoimmune disease is a highly com-
plex process, the extracellular exposure of intracellular 
antigens is generally accepted as the fundamental step in 
the autoimmune response and the production of autoan-
tibodies.
SVV is a systemic autoimmune disease which caus-
es chronic inflammation of small blood vessels, e.g. in 
lungs, skin or kidneys, and is associated with the pres-
ence of anti-neutrophil cytoplasmic antibodies (ANCA). 
The main targets for ANCA are MPO (associated with 
microscopic polyangiitis) and PR3 (associated with We-
gener’s granulomatosis) (Kallenberg et al., 2006; Kessen-
brock et al., 2009). Moreover, it was observed that the 
binding of ANCA to MPO or PR3 activated the neu-
trophils and promoted netosis (Kessenbrock et al., 2009). 
Established ANCA-MPO-complexes were also able to 
activate mDC. Treatment with DNase not only caused 
inhibition of NET formation but also prevented vessel 
inflammation, confirming the involvement of NETs in 
small vessel damage and SVV disease development (San-
galetti et al., 2012).
Neutrophils of SLE patients are activated and more 
likely to form NETs (Brinkmann & Zychlinsky, 2012). 
This finding correlates with an increased level of circu-
lating DNA in the plasma of SLE patients as well as 
with the presence of antibodies against NET-associated 
Figure 3. Role of NETs in increasing mucus viscosity. 
In response to microbial infections neutrophils are recruited from the capillaries to alveoli (A). CF 
patients produce a lot of mucus that is an excellent environment for bacteria development and 
can lead to chronic infection. Pathogens stimulate neutrophils to release NETs (B), an ineffective 
NET clearance causes epithelium injury by NET components (C) and increases mucus viscosity 
owing to the presence of DNA fibres (D).
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proteins (Tsokos, 2011). More than 70% of NET com-
ponents are potent autoantigens in SLE and other auto-
immune diseases (Knight et al., 2012; Darrah & Andrade, 
2012).
The NET formation entails a unique histone modifi-
cation in which arginine is converted to citrulline. The 
citrullinated histones seem not only to damage endothe-
lial cells (Gupta et al., 2010) but can also constitute new 
autoantigens for the immune system (Darrah et al., 2012; 
Liu et al., 2012), which is additionally activated by pro-
longed exposure of NET proteins owing to the protec-
tion of DNA from degradation by DNase inhibitors 
(Lande et al., 2011). Such inhibitory effects can result 
from the protective function of the antibacterial peptide 
LL-37, another component of NETs (Lande et al., 2011), 
a high level of anti-NET antibodies or an increased 
deposition of the complement protein C1q (Leffler et al., 
2012).
The breakdown of tolerance to the immune com-
plexes (IC) formed in SLE causes multi-organ inflamma-
tion and damage (Garcia-Romo et al., 2011). Moreover, 
IC stimulate other neutrophils to produce NET (Knight 
et al., 2012) and activate plasmacytoid dendritic cells 
through Toll-like receptors (TLR7) to secrete interferon 
(IFN-α) (Crispín et al., 2010; Tsokos, 2011; Garcia-Romo 
et al., 2011). All the proposed models of the interplay 
between netosis and autoimmune diseases are discussed 
in detail by (Darrah & Andrade, 2012).
Thrombosis
Deep vein thrombosis (DVT) is a disease that may 
be complicated by pulmonary or venous embolism and 
leads to serious multiple organ ischemia. The factors that 
contribute to thrombosis, called Virchow’s triad, include: 
stasis (low vascular blood flow), endothelial or vessel wall 
damage and hypercoagulability. Stasis leads to platelet 
deposition, an increase in the concentration of procoagu-
lant factors and thrombus formation (Line, 2001). Ad-
ditionally, endothelium may be activated by local hypoxia 
(Hamer et al., 1981). Activated endothelium releases von 
Willebrand factor (vWF) which is necessary for platelet 
recruitment and adhesion (Brill et al., 2011). Moreover, 
activated endothelium produces compounds that, upon 
contact with neutrophils, stimulate netosis which, in 
turn, promotes endothelial damage (Fig. 4) (Gupta et al., 
2010). Application of deoxyribonuclease 1 (DNase 1) in 
a murine model of DVT protected mice from DVT and 
revealed that the cleavage of NETs by DNase1 prevents 
the cascade of events leading to thrombosis (Brill et al., 
2012).
Thrombosis can also be initiated by the release of the 
tissue factor (TF) as well as by cytokines produced dur-
ing inflammatory processes associated with infections, 
autoimmune disorders and cancer (Line, 2001; Fuchs et 
al., 2012). TF binds factor VII to give TF-FVIIa com-
plex which is able to activate the coagulation cascade 
with clot formation (Wolberg et al., 2012). A recent 
finding that TF can be produced by neutrophils and ex-
pulsed to the vein during NET formation is the first evi-
dence that neutrophils and netosis provide an interface 
between inflammation and thrombosis (Von Brühl et al., 
2012; Fuchs et al., 2012). In the model studies, the neu-
trophils, after stimulation with P-selectin or fMLP (but 
not PMA), expressed TF intracellularly and only a small 
fraction of TF translocated to the cell surface. The same 
effects were observed for neutrophils isolated from pa-
tients with ARDS (Kambas et al., 2008). However, neu-
trophils from patients with sepsis contain a large amount 
of TF delivered and released by NETs (Kambas et al., 
2012). Additionally, NE present in NETs can regulate 
coagulation pathway by proteolytic cleavage of TF path-
way inhibitors and enhancement of Factor Xa activity 
(Steppich et al., 2008).
NETs, assisted by DNA and histones, also bind factor 
XII thereby stimulating fibrin formation via the intrinsic 
coagulation pathway (Von Brühl et al., 2012).
Figure 4. Clot formation after blood vessel injury. 
The damage of blood vessels causes the release of von Willebrand factor (vWF) by endothelial cells (A), which in turn activate platelets 
(B) and neutrophils. Moreover, neutrophils can be stimulated by activated platelets (C). This leads to changes in nucleus (D) and in con-
sequence to NET release. NETs bind the blood cells (e.g. RBC, platelets) and proteins, such as fibrin, leading to clot formation (E).
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Another way of NET contribution to thrombus for-
mation is platelet entrapment and activation (Ma & 
Kubes, 2008). NET fibres bind platelets directly or indi-
rectly, and support their aggregation (Fuchs et al., 2011). 
The first step of platelet binding involves Toll- like re-
ceptors (Semeraro et al., 2011) or is based on electro-
static interaction between histones located in NETs and 
phospholipids or carbohydrates of platelets. In another 
model, the platelet-NET interactions were proposed to 
be mediated by adhesion molecules: vWF, fibronectin or 
fibrinogen (Fuchs et al., 2010; Brill et al., 2012). Addition-
ally, platelets bound to NETs can be activated by com-
ponents of traps, especially by histones, through stimula-
tion of the calcium flux (Fuchs et al., 2011) or by neutro-
phil proteases, which proteolytically activate the platelet 
receptors (Si-Tahar et al., 1997). This process may be 
accelerated, as activated platelets cause further NET re-
lease that increases endothelial permeability (Fuchs et al., 
2010; Brill et al., 2012).
Based on the observations described above we can 
conclude that neutrophils, platelets and endothelial cells 
effectively interact with the coagulation factors. The syn-
ergistic effect of different NET functions, i.e., antimicro-
bial and prothrombotic, seems to be essential to preserve 
homeostasis in infectious disease, especially in sepsis.
NETs and cancer
A hypothesis that netosis has some significance in 
cancer has arisen from recent studies showing that neu-
trophils, found in large quantities in plasma of cancer 
patients, possessed pro- and anti-tumour activities (Souto 
et al., 2011). On the one hand, neutrophils favour mi-
gration of cancer cells by directly interacting with them 
(Huh et al., 2010), promote tumour growth by secreting 
matrix metalloproteinases (Acuff et al., 2006) or tumour 
angiogenesis and neovascularization (Masson et al., 2005) 
as well as establish the environment for metastatic can-
cer cells (Kowanetz et al., 2010). On the other hand, 
activated neutrophils exert cytotoxic effects on tumour 
cells by releasing ROS or defensins (Granot et al., 2011). 
Recently, it has been observed that the granulocyte col-
ony-stimulating factor (G-CSF), produced by many tu-
mours and found in the circulation of cancer patients, 
not only influenced the mobilisation and activation of 
neutrophils but also triggered NET formation (Demers 
et al., 2012). Moreover, in mice at the late-stage of can-
cer a high quantity of plasma DNA and citrullinated his-
tones was detected. Their production correlated with an 
increased level of neutrophil markers and micro-thrombi 
formation in the lung (Demers et al., 2012). This is the 
first evidence of correlations between cancer or metas-
tasis and NET formation and thrombosis. However, at 
the actual stage of our knowledge, it is difficult to decide 
whether netosis plays a pro- or anti-tumorigenic role. It 
was speculated that NET components like MPO, pro-
teinases and histones could be cytotoxic to tumour cells 
and inhibit their growth.
Moreover, it was also suggested that NETs could 
serve as a scaffold for the capture of tumour cells and, 
thereby, prevent their further dissemination (Berger-
Achituv et al., 2013). Alternatively, NETs, through the 
action of their proteinous components could promote 
extravasation and metastasis. Finally, NETs could adhere 
to the metastatic cells and by recruiting platelets could 
protect them and attenuate the immune response (Dem-
ers & Wagner, 2013).
Nevertheless, better understanding of the function of 
NETs in tumour progression can lead in the future to 
the development of new prognostic markers or anti-can-
cer therapies.
CONCLUSION
NET production by neutrophils plays an essential role 
in immune response to infection. The chromatin scaf-
fold binds pathogens preventing their dissemination and 
limiting the inflammation area while the components 
of NETs very efficiently kill the trapped pathogens by 
oxidative and non-oxidative mechanisms. Regardless of 
antimicrobial function, NETs participate also in many 
non-infectious diseases, autoimmune and inflammatory 
disorders, including chronic lung disease, sepsis, and 
vascular disorders. The increased autoreactivity towards 
NET constituents is a result of excessive netosis or di-
minished NET clearance. Although a range of biological 
events activating NET release is currently under exces-
sive exploration, the mechanisms of its regulation are 
still unknown. The discovery of the association of neto-
sis with pathophysiological and immunological processes 
has not only helped to understand NET functioning 
during specific disease states or microbial infections but 
also may potentially lead to the discovery of new effec-
tive therapeutic agents.
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